Microvesicles as Mediators of Tissue Regeneration

Keith Sabin, Nobuaki Kikyo

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


The use of stem cells in the treatment of various diseases and injuries has received increasing interest over the past decade. Injected stem cells, such as mesenchymal stem cells, stimulate tissue repair largely through the secretion of soluble factors that regulate various processes of tissue regeneration, including inflammatory responses, apoptosis, host cell proliferation, and angiogenesis. Recently, it has become apparent that stem cells also use membranous small vesicles, collectively called microvesicles (MVs), to repair damaged tissues. MVs are released by many types of cells and exist in almost all types of body fluids. MVs serve as a vehicle to transfer protein, mRNA, and miRNA to distant cells, altering the gene expression, proliferation, and differentiation of the recipient cells. Although animal models and in vitro studies have suggested promising applications for MV-based regeneration therapy, its effectiveness and feasibility in clinical medicine remain to be established. Further studies of the basic mechanisms responsible for MV-mediated tissue regeneration could lead to novel approaches in regenerative medicine.

Original languageEnglish (US)
Title of host publicationTranslating Regenerative Medicine to the Clinic
PublisherElsevier Inc.
Number of pages10
ISBN (Electronic)9780128005521
ISBN (Print)9780128005484
StatePublished - Jan 1 2016


  • Cardiac progenitor cell
  • Embryonic stem cell
  • Exosome
  • Injury
  • Mesenchymal stem cell
  • MicroRNA
  • Microparticle
  • Microvesicle
  • Regeneration
  • Tissue repair


Dive into the research topics of 'Microvesicles as Mediators of Tissue Regeneration'. Together they form a unique fingerprint.

Cite this